Company Filing History:
Years Active: 2014
Title: Sarashnee Moonisami: Innovator in Gastroretentive Pharmaceutical Dosage Forms
Introduction
Sarashnee Moonisami, based in Sunninghill, South Africa, is a notable inventor recognized for his contribution to the field of pharmaceuticals. With a focus on enhancing drug delivery systems, his work has significant implications for the effectiveness of orally administered medications.
Latest Patents
Sarashnee holds a patent for a "Multi-unit gastroretentive pharmaceutical dosage form comprising microparticles." This innovative invention pertains to an orally administrable dosage form that includes at least one pharmaceutically active ingredient and a polymeric adjuvant. The purpose of the adjuvant is to ensure that the dosage form remains in a targeted area of the gastrointestinal tract long enough for the active ingredients to be released and absorbed effectively. This dosage form ideally comprises two or more pharmaceutically active ingredients, allowing for the targeted delivery to different regions within the gastrointestinal system.
Career Highlights
Sarashnee is affiliated with the University of the Witwatersrand in Johannesburg, where he engages in advanced research focusing on pharmaceutical sciences. His expertise not only contributes to academic progress but also advances practical applications in healthcare.
Collaborations
Throughout his career, Sarashnee has collaborated with esteemed colleagues, including Viness Pillay and Yahya Essop Choonara. These partnerships enhance the scope and impact of their research, fostering innovation in pharmaceutical technology.
Conclusion
Sarashnee Moonisami's work in developing gastroretentive pharmaceutical dosage forms underscores the importance of innovative approaches to improve medication delivery. His contributions through patenting and collaboration reflect a commitment to enhancing patient care and the efficacy of therapeutics, positioning him as a prominent figure in the realm of pharmaceutical innovations.